- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01099189
Vein Histology in Arteriovenous Fistulas and Its Effect on Fistula Surgery Success
A Cohort Study of the Histopathological Changes Evident in Vein Wall at the Time of Arteriovenous Dialysis Access Fistulas and the Effects of Such Changes on Biomechanical Compliance and Patient's Clinical Outcomes in a University Teaching Hospital.
Patients whose kidneys have failed need to receive dialysis treatment, most commonly with a dialysis machine. In order to be connected to the machine an operation is often performed to join an artery to a vein in the arm. This forms what is known as an arteriovenous fistula. The fistula causes an increase in the flow of blood through the vein and the vein reacts to this by becoming bigger and thicker, making it easier to connect the patient to the machine.
The success rate for the operation is relatively low and only approximately 65 from every 100 operations is still working after a year. It is thought that one factor that may cause problems with the fistula is the ability of the vein to stretch in response to increased blood flow. Previous research has shown that veins in kidney failure patients look different to those of people whose kidneys are working when viewed under a microscope.
The investigators aim to study the structure of the vein that is used in making fistulas with a microscope and also to test it in an engineering laboratory to see how much it will stretch. The investigators hope that gaining information about the structure of the vein and its ability to stretch will help determine what it is about the vein that affects how well it works as part of a fistula. This information may help surgeons select the best possible vein in a given patient to give the best chance of a working fistula in the future.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Yorkshire
-
Hull, Yorkshire, United Kingdom, HU3 2JZ
- Academic Vascular Surgery Unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients referred to vascular consultants for AV fistula formation for haemodialysis access.
- Ability to give informed written consent
- Aged over 18 at time of referral
Exclusion Criteria:
- Veins identified on preoperative ultrasound scanning to be of a calibre too small to allow sufficient material to be obtained for biomechanical testing (<3mm diameter).
- Inability to give informed written consent
- Aged under 18 at time of referral
- Inability to attend follow-up appointments
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Observed cohort
All patients recruited.
Observed for clinical outcomes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary failure of access - Immediate/early thrombosis or failure to mature.
Time Frame: within 30 days of formation
|
Failure to mature or thrombosis of fistula
|
within 30 days of formation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Duplex findings of evidence of stenosis and correlation to compliance or histological findings
Time Frame: 6 months
|
6 months
|
|
Correlation between biomechanical compliance and histological measures of pre existing venous pathology
Time Frame: 6 months
|
6 months
|
|
Correlation between biomechanical compliance testing and clinical outcomes
Time Frame: 6 months
|
6 months
|
|
Assisted primary and secondary patency rates at 3 and 6 months post fistula formation
Time Frame: 6 months
|
6 months
|
|
Functional primary patency
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Ian C Chetter, MBChB FRCS, University of Hull
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Access 4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Replacement Therapy
-
Haisco Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Universitätsklinikum Hamburg-EppendorfCompletedReplacement Therapy, RenalGermany
-
Drexel UniversityThe Center for Pediatric PharmacotherapyRecruitingPharmacokinetics | Renal Replacement TherapyUnited States
-
Shanghai Jiao Tong University School of MedicineCompletedThe Effect of Different Dosages of Solute Clearance on Outcome in Twice Weekly Hemodialysis PatientsHemodialysis | Renal Replacement TherapyChina
-
AKI Critical Care Research FoundationUnknownContinuous Renal Replacement TherapyUnited States
-
Zhujiang HospitalRecruitingContinuous Renal Replacement Therapy (CRRT)China
-
University of California, San DiegoCompletedHormone Replacement Therapy | Renal Function | TransgenderUnited States
-
Fujian Provincial HospitalRecruitingContinuous Renal Replacement Therapy | Regional Citrate Anticoagulation | Renal InjuryChina
-
Chulalongkorn UniversityCompletedContinuous Renal Replacement Therapy | Regional Citrate Anticoagulation | Ionized CalciumThailand
-
University of Erlangen-Nürnberg Medical SchoolUniversitätsklinikum Hamburg-Eppendorf; University Hospital FrankfurtCompleted